Skip to main content
. 2022 Sep 8;10(9):1497. doi: 10.3390/vaccines10091497

Figure 2.

Figure 2

Geometric mean concentration of anti-RBD IgG pre- and post-intradermal (ID) booster dose in the initial phase (A) and in initial and extended phase (B). Intramuscular (IM) boosting of the same vaccine regimens from the previous study [19] is included as a reference group. Error bars represent geometric mean concentration, plus 95% confidence intervals. BAU: binding antibody units.